Haploidentical Stem Cell Transplantation

Introduction:

Matching a patient's tissue type—more precisely, their human leukocyte antigen (HLA) tissue type—with a related or unrelated donor is known as an allogeneic hematopoietic stem cell (HPC) transplant. All cells in the body include HLA proteins, the primary means by which the immune system distinguishes between foreign and native cells.

The likelihood of a successful transplant increases with the degree of HLA matching between a donor and recipient. If the HLA match is not near enough, the donor's immune system, which travels with the donated stem cells, will assault the recipient's tissues. The term "graft versus host disease" (GVHD) describes this process.

A sibling or unrelated donor who shares the same HLA is accessible for about 70% of patients in need of an allogeneic transplant due to a hematological malignancy or bone marrow failure syndrome.

Recent developments in medicine have allowed for the use of partially matched or haploidentical-related donors for patients in need of a stem cell transplant who do not have an HLA-matched related or unrelated donor. A haploidentical-related donor can be the recipient's parent, sibling, or kid and is often a 50 percent match.

How does Haploidentical Stem Cell Transplantation treat Blood Cancers and Disorders?

Bone marrow and blood cells must be in good condition to be healthy. If the illness affects the blood or bone marrow, a stem cell transplant may be the best course of action. It gives some individuals hope for a possible remedy.

The healthcare team will inject a matching donor's fresh, healthy stem cells into the bloodstream during the transplant. They will eventually engraft—or attach and grow—into the bone marrow to begin producing new blood cells.

Every attempt is made to match one with a donor if they require a stem cell transplant. The human leukocyte antigen (HLA) tissue type determines matching. The unique genetic makeup includes the HLA, which is what defines an individual, but finding the ideal match is not always achievable.

Using a family member whose tissue type is half-matched to the patient, they can undergo a haploidentical transplant as an alternative. Kids are never really capable of matching their biological parents, and vice versa. Half of the time, siblings are not a good fit for one another.

Because practically everyone has at least one potential haploidentical match in their family, one has a wider selection of possible donors.

For Whom Would a Haploidentical Transplant Be Required?

Haploidentical transplants are becoming more popular due to their ability to locate eligible donors rapidly. If a donor who is a perfect match cannot be identified, people may be able to get a haploidentical transplant depending on the type of blood cancer or blood condition one has. The optimal choice for the circumstances will be made by the transplant team.

A haploidentical transplant carries a higher risk of post-transplant problems due to more mismatches between the recipient and donor. However, if an individual does not have an HLA-matched donor, they can be an excellent alternative due to advancements in transplant procedures and post-transplant care.

What Happens During the Entire Procedure of Haploidentical Stem Cell Transplantation?

1. Before the Surgery: To get the bone marrow and immune system ready for the new cells, conditioning therapy will be administered. Chemotherapy and occasionally total body irradiation (TBI), a form of radiation therapy, are involved. This also goes after any residual aberrant cells that are the source of the illness.

2. During the Surgery: Usually, the transplant happens the day following the conclusion of conditioning therapy. The stem cells from the relative will be sent to one in a little bag as a liquid. Similar to a blood transfusion, they will be injected into the bloodstream through a tiny tube. One will not experience any pain during the transplant because there is not an actual surgery involved.

3. Post-surgery:

• Additional chemotherapy.

• More lymphocytes, a type of white blood cell, are being infused.

What Is the Prognosis of Haploidentical Stem Cell Transplantation?

Following the transplant, most people will spend three or four weeks in the hospital. Patients will be kept in protective isolation throughout this period to allow the immune system to begin healing. There will be safety measures in place in one's room to lessen the possibility of contracting an infection. The recuperation will probably have an impact on several facets of life after returning home. It can take six to twelve months for the level of activity to stabilize.

What Are the Possible Side Effects of Haploidentical Stem Cell Transplantation?

Receiving a transplant requires extensive medical care that will affect physical and mental health. The transplant team will discuss potential risks and side effects with the patient so that they may decide on the best course of action.

Individual differences exist in the length and intensity of side effects. They are frequently brought on by both the transplant itself and the conditioning treatment.

A few of the short-term side effects are as follows:

• Elevated chance of infection.

• Mouth pain (mucositis).

• Renal and liver issues.

• Fatigue.

• Diarrhea as well as feeling unwell.

• Appetite decline.

• Hair fall.

A few of the long-term term side-effects are as follows:

• Weariness.

• An elevated risk of infection.

• The illness is known as "graft versus host" (GvHD).

Following the transplant, the developing immune system and other bodily cells will have minor variations. As it perceives the cells as "different," the new immune system may damage them as a result. Graft versus host disease (GvHD) is the term for this.

Although it can affect any region of the body, it usually affects the skin, stomach, and liver. It may be minor or severe and last for a short while. The transplant team will treat patients to help manage the immune system and constantly watch for any indications of GvHD.

Conclusion:

The process of matching a patient's tissue type—more precisely, their human leukocyte antigen tissue type—with that of a related or unrelated donor is known as an allogeneic hematopoietic stem cell transplant. All of the cells in the body include HLA proteins, which are the primary means by which the immune system distinguishes between foreign and native cells. An increased probability of successful transplantation is associated with a closer HLA match between the donor and recipient.